Elevated Red Cell Distribution Width Is Associated With Impaired Reverse Ventricular Remodeling and Increased Mortality in Patients Undergoing Cardiac Resynchronization Therapy

Congestive Heart Failure

Volumn 18, Issue 2, 2012, Pages 79-84

  Rickard, John ^a   Kumbhani, Dharam J ^b   Gorodeski, Eiran Z ^a   Martin, David O ^a   Grimm, Richard A ^a   Tchou, Patrick ^a   Lindsay, Bruce D ^a   Tang, W H ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; ECHOCARDIOGRAPHY; ELEVATED RED CELL DISTRIBUTION WIDTH; ERYTHROCYTE PARAMETERS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE HEART VENTRICLE REMODELING; REVIEW;

CARDIAC RESYNCHRONIZATION THERAPY; CONFIDENCE INTERVALS; ERYTHROCYTES; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OHIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TIME FACTORS; VENTRICULAR REMODELING;

EID: 84858793610     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00267.x     Document Type: Review

References (21)

1. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
2. Abraham WT, Fisher WG, Smith AL, et al. Cardiac-resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
3. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
4. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50:40-47.
5. Wilton SB, Shibata MA, Sondergaard R, et al. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol. 2008;23:219-227.
6. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
7. Hosmer DW. Model building. In: Hosmer DW, Lemeshow S, eds. Applied Logistic Regression, 2nd edn. New York: Wiley; 2000:91-114.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
9. Marsan NA, Westenberg JJ, Ypenburg C, et al. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J. 2009;19:1360-1367.
10. Marsan NA, Bleeker GB, van Bommel RJ, et al. Comparison of time course of response to cardiac resynchronizaion therapy in patients with ischemic versus nonischemic cardiomyopathy. Am J Cardiol. 2009;103:690-694.
11. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277:103-108.
12. Cavusoglu E, Chopra V, Gupta A, et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol. 2010;141:141-146.
13. Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009;104:868-872.
14. Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163-168.
15. Foerhecz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659-666.
16. Silverberg DS. Outcomes of anaemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant. 2003;18(suppl 2):7-12.
17. Freeman LM. The pathophysiology of cardiac cachexia. Curr Opin Support Palliat Care. 2009;3:276-281.
18. Demir A, Yarali N, Fisgin T, et al. Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia. Pediatr Int. 2002;44:612-616.
19. Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16:230-238.
20. Ozkalemkas F, Ali R, Ozkocaman V, et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer. 2005;5:144.
21. Spell DW, Jones J, Harper WF, Bessman DJ. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37-42.